Linvesta Emp 25mg 5mg Tablets

Product Overview:
Linvesta Emp 25mg 5mg Tablets are a prescription medication used to treat type 2 diabetes. These tablets contain the active ingredient Empagliflozin, which helps lower blood sugar levels by increasing the amount of glucose excreted in the urine. This can help control blood sugar levels and reduce the risk of complications associated with diabetes.


Key Benefits:
- Helps lower blood sugar levels
- Reduces the risk of cardiovascular events in patients with type 2 diabetes
- Can be used alone or in combination with other diabetes medications
- Easy-to-take oral tablets
- May promote weight loss in some patients


How It Works:
Empagliflozin, the active ingredient in Linvesta Emp tablets, works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. This mechanism helps the kidneys remove excess glucose from the bloodstream through the urine, leading to lower blood sugar levels.


Directions for Use:
- Take Linvesta Emp tablets exactly as prescribed by your healthcare provider.
- Swallow the tablets whole with a full glass of water.
- You can take this medication with or without food.
- Follow any dietary or exercise recommendations provided by your doctor.


Precautions:
- Inform your doctor of any allergies or medical conditions before taking Linvesta Emp tablets.
- Monitor your blood sugar levels regularly as directed by your healthcare provider.
- Avoid excessive alcohol consumption while taking this medication.
- Do not stop taking Linvesta Emp tablets without consulting your doctor.


Storage Instructions:
Store Linvesta Emp tablets at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children.


Manufacturer Information:
Linvesta Emp 25mg 5mg Tablets are manufactured by Wilshire Pharmaceuticals, a trusted pharmaceutical company known for producing high-quality medications. Wilshire is committed to providing effective and safe treatments for various health conditions, including diabetes.